Dr. Vibeke Strand: The Current State of Immunology Biosimilars and the Promise of Future Savings
Season 6, Episode 9, May 14, 2023, 11:00 AM
In light of 2 blockbuster originators, namely Humira (adalimumab) and Stelara (ustekinumab), losing market exclusivity in 2023, 3 doctors penned supplement in The American Journal of Managed Care®. On this episode, Vibeke Strand, MD, one of the co-authors, explored how health systems can take charge and boost biosimilar adoption.
Show notes
To read all the articles within the supplement, click here.
To read the article references in this episode, click here.
To read all the articles within the supplement, click here.
To read the article references in this episode, click here.